KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics, Inc. (PVLA) Return on Assets (2016 - 2022)

Palvella Therapeutics (PVLA) has disclosed Return on Assets for 11 consecutive years, with 0.02% as the latest value for Q3 2024.

  • On a quarterly basis, Return on Assets rose 49.0% to 0.02% in Q3 2024 year-over-year; TTM through Sep 2024 was 0.02%, a 49.0% increase, with the full-year FY2023 number at 0.36%, up 71.0% from a year prior.
  • Return on Assets was 0.02% for Q3 2024 at Palvella Therapeutics, up from 0.15% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.14% in Q1 2024 to a low of 0.57% in Q1 2023.
  • A 5-year average of 0.29% and a median of 0.33% in 2021 define the central range for Return on Assets.
  • Peak YoY movement for Return on Assets: fell -25bps in 2021, then skyrocketed 71bps in 2024.
  • Palvella Therapeutics' Return on Assets stood at 0.3% in 2020, then decreased by -8bps to 0.33% in 2021, then tumbled by -35bps to 0.44% in 2022, then soared by 32bps to 0.3% in 2023, then soared by 105bps to 0.02% in 2024.
  • Per Business Quant, the three most recent readings for PVLA's Return on Assets are 0.02% (Q3 2024), 0.15% (Q2 2024), and 0.14% (Q1 2024).